CONSUN PHARMA (01681) purchased approximately 100,000 shares for around HK$1.5413 million on October 20th.
Kangcon Pharmaceutical (01681) announced that on October 20, 2025, it will spend approximately HK$1.5413 million to buy back 10...
CONSUN PHARMA (01681) announced that on October 20, 2025, it spent approximately HKD 1.5413 million to repurchase 100,000 shares.
Related Articles
Dragon King GP (08493): Lau Shingshan resigns as Independent Non-executive Director.
Shareholder Kunlun Investment plans to reduce its holdings of Western Regions Tourism Development (300859.SZ) by no more than 3%.
ZMJ Group (00564): Cheng Jinglei resigns as independent non-executive director.
Dragon King GP (08493): Lau Shingshan resigns as Independent Non-executive Director.
Shareholder Kunlun Investment plans to reduce its holdings of Western Regions Tourism Development (300859.SZ) by no more than 3%.
ZMJ Group (00564): Cheng Jinglei resigns as independent non-executive director.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
